Curative Biosciences, Inc. (CBDX) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Miami, FL, United States. The current CEO is Katherine T. Alverson West.
CBDX has IPO date of 2004-08-26, listed on the Other OTC, a market capitalization of $25.79K.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
